How immune system impact the nervous system

Bohan Huang

doi:10.54097/f2k6dq53

Authors

Bohan Huang

DOI:

https://doi.org/10.54097/f2k6dq53

Keywords:

Immune system; nervous system; autoimmune encephalitis.

Abstract

Immune system and nervous system are both important. Adaptive immune system and innate immune system are two categories of the immune system. Both types of system have a lot of organs that has different types of function. Both the CNS and the PNS share this characteristic. The nervous system disorders have some relationship with the immune cells being too activated. The T-cells, B-cells, macrophages, and glial cells will become to activate and accidently kill some cells in the nervous systems to cause the diseases. However, these types of disorders will have a varying cause and the scientists have to spend more studying on that. Autoimmune encephalitis (AE), Acute disseminated encephalomyelitis (ADEM) and Multiple sclerosis (MS) are both common disease with a huge prevalence around the world. This research paper has found out the treatment and pathogenesis of these diseases. The main cause of these types of diseases are the disorders of immune cells.

Downloads

Download data is not yet available.

References

Schleimer RP, Kato A, et al. Epithelium: at the interface of innate and adaptive immune responses. J Allergy Clin Immunol. 2007 Dec;120(6):1279-84.

Kmar BV, Connors TJ, et al. Human T Cell Development, Localization, and Function throughout Life. Immunity. 2018 Feb 20;48(2):202-213.

Ludwig PE, M Das J. Histology, Glial Cells.. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-.

Ciurkiewicz M, Herder V, et al. Beneficial and Detrimental Effects of Regulatory T Cells in Neurotropic Virus Infections. Int J Mol Sci. 2020 Mar 2;21(5):1705.

Dubey, Divyanshu et al. “Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis.” Annals of neurology vol. 83,1 (2018): 166-177.

Gu Y, Zhong M, et al. Epidemiology of Antibody-Positive Autoimmune Encephalitis in Southwest China: A Multicenter Study. Front Immunol. 2019 Nov 12;10:2611.

Johns Hopkins Medicines, Encephalitis, cited time 2023.9.1, https://www.hopkinsmedicine.org/health/conditions-and-diseases/encephalitis

Brain institute, Autoimmune Encephalitis, cited time 2023.9.3, https://www.ohsu.edu/brain-institute/autoimmune-encephalitis

Louveau A, Smirnov I, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015 Jul 16;523(7560):337-41.

Tüzün, E. et al. Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma. Acta Neuropathol. 118, 737–743 (2009).

Bhasin M, Wu M, et al. Modulation of microglial/macrophage activation by macrophage inhibitory factor (TKP) or tuftsin (TKPR) attenuates the disease course of experimental autoimmune encephalomyelitis. BMC Immunol. 2007 Jul 16;8:10.

Menge T, Hemmer B, Nessler S, et al. Acute Disseminated Encephalomyelitis: An Update. Arch Neurol. 2005; 62(11):1673–1680.

Alexander M, Murthy JM. Acute disseminated encephalomyelitis: Treatment guidelines. Ann Indian Acad Neurol. 2011 Jul; 14(Suppl 1): S60-4.

Titcomb TJ, Bao W, Du Y, Liu B, Snetselaar LG, Wahls TL. Association of multiple sclerosis with risk of mortality among a nationally representative sample of adults in the United States. Mult Scler J Exp Transl Clin. 2022 May 30; 8(2):20552173221104009.

Alex Y. Chen, Amy O. Chonghasawat, Kevin L. Leadholm, Multiple sclerosis: Frequency, cost, and economic burden in the United States, Journal of Clinical Neuroscience, Volume 45, 2017, Pages 180-186, ISSN 0967-5868

Loma I, Heyman R. Multiple sclerosis: pathogenesis and treatment. Curr Neuropharmacol. 2011 Sep; 9(3):409-16.

J, Hug A, Veihover A, Fritzching B, Falk CS, Filser A, Vetter T, Milkova L, Korporal M, Fritz B, Storch-Hagenlocher B, Krammer PH, Suri-Payer E, Wildeman B. Reduced suppressive effect of CD4+CD25 high regulatory T cells on the T cell immune response against myelin oligodendrocyte glycoprotein in patients with multiple sclerosis. Eur. J. Immunol. 2005; 35:3343–3352.

Kasper L, Shoemaker J. Multiple sclerosis immunology: The healthy immune system vs. the MS immune system. Neurology. 2010; 74: S2–S8.

Pappas D, Oksenberg J. Multiple sclerosis pharmacogenomics: maximizing efficacy of therapy. Neurology. 2010;74: S62–S69